John David Finley insider trades
Open-market stock purchases and sales by John David Finley, CEO CFO at Palisade BIO, Inc, from SEC Form 4 filings since Apr 27, 2021.
Track record: 56% of 9 scored buys are up 5% or more since purchase, averaging +44%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 6, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Oct 6, 2026 | PALI Palisade BIO, Inc | Sold (not open market) | $2.1M |
| Oct 6, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Oct 6, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Aug 19, 2026 | PALI Palisade BIO, Inc | Sold (not open market) | — |
| Aug 19, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Jul 7, 2026 | PALI Palisade BIO, Inc | Sold | $303K |
| Jul 7, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | $93 |
| Jul 7, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Jul 6, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Jul 6, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Feb 12, 2026 | PALI Palisade BIO, Inc | Sold | $6.8K |
| Feb 11, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
| Feb 9, 2026 | PALI Palisade BIO, Inc | Bought (not open market) | — |
Companies traded
- PALI Palisade BIO, Inc: 12 buys, 2 sales, last Oct 6, 2026